Navigation Links
Divine Skin Posts Record Q2 Revenue of $2.33 Million, up 79 Percent From 2010
Date:8/23/2011

MIAMI BEACH, Fla., Aug. 23, 2011 /PRNewswire/ -- Biotechnology leader Divine Skin Inc. (DSKX) posted its highest quarterly revenue, $2.33 million, in the second quarter. The expanding innovator of personal care solutions credits recent investments in production for clearing backorders and accelerating sales, which are 79 percent ahead of the same period in 2010.

"One of our challenges has been keeping up with demand," said Divine Skin CEO Daniel Khesin. "We have invested significant resources into setting up a more robust operations platform. Now we have the right people in the right jobs managing the right plans for procurement, manufacturing, and accounting infrastructure. We will therefore continue to scale up to much more impressive numbers."

The results come after a busy four months of announcements:

  • Naming of cosmetics veteran Robin Powell, respected for his success at Sebastian and TIGI, as president.
  • Explosive growth in salon distribution, including new channels totaling thousands of additional doors both domestically and abroad.  
  • Plans for an oral analgesic to compete with Tylenol, Advil, and aspirin.
  • Expansion into advanced nutritional supplements with NutraOrigin.
  • Agreement for India's largest pharmaceutical company to sell DS Laboratories treatments.

Divine Skin maintains a core focus on biotechnology development while building its consumer goods business. It's ongoing clinical studies for topical therapies have helped identify new molecules and many proprietary technologies in the treatment of common skin conditions such as alopecia. Recently the company has announced the launch of Nanoxidil, a new material to designed to surpass the efficacy of minoxidil. This kind of innovations within personal care is expected to maintain Divine Skin's position as a category leader in niche categories and drive strong revenue growth.

"At the
'/>"/>

SOURCE Divine Skin Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Biotech Developer Divine Skin (DSKX) Debuts New Hair-Growth Molecule Nanoxidil
2. Robin Powell Becomes President at Biotech Leader Divine Skin (DSKX)
3. First-quarter 2011 Sales Reach $2.25M — 126% Growth Over Q1 of 2010 — for Biotech Developer Divine Skin
4. Divine Skin Announces Four Deals for Explosive Distribution Growth
5. Divine Skin Posts Record Sales for 2010: Up 55% Over 2009
6. Fiberstar Posts Strong Second Quarter Operating Results on Continued Rising International Demand
7. Biotech Posts Strong Third Quarter Performance as Capital Markets Go on a Tear
8. Switzerland Posts Biotech Gains in 2009
9. OpenQ Posts a 200% Revenue Growth in the First Half of 2009
10. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
11. Synvista Therapeutics Posts Letter to Stockholders on Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)... 24, 2014   BioLife Solutions , Inc. (NASDAQ: ... clinical grade hypothermic storage and cryopreservation freeze ... cells and tissues  ("BioLife" or the "Company"), today announced that ... May 4, 2015 (the "Annual Meeting"). Because the ...
(Date:12/24/2014)... Earlier this year in a June 24 international ... Stem Cell Technology Center, LLC ( ASCTC ) focused attention ... adult tissue stem cells. His title “Asymmetric Self-Renewal by ... Future,” embodied the essence of his message to congress participants. ...
(Date:12/24/2014)... 23, 2014 According to Ross Selinger, President ... of ITRA Global, the national office market continues to be ... This is evidenced by the third quarter’s surprising 3.9% GDP, ... Low energy costs have held inflation down and the Fed ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3
... MSEDMONTON, March 17 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: ... sclerosis (MS), today announced financial and operational results for ... demonstrated the ability to safely affect MS progression in ... of the Canadian/European trial (MAESTRO-01) in the second half ...
... LONDON and WASHINGTON, March 17 Gentag, Inc. (Gentag) ... VCG & Associates Inc. and Talisman Management Ltd. to ... of all or parts of its IP portfolio. ... pharmaceutical and medical diagnostic uses on a global or ...
... AMGN ) will present at the Cowen and ... at the Boston Marriott Copley Place, Boston, Mass., beginning at ... President of North American Commercial Operations, will present. Live audio ... can be accessed from Amgen,s Web site, www.amgen.com , ...
Cached Biology Technology:BioMS Medical Announces 2008 Year End Results 2BioMS Medical Announces 2008 Year End Results 3BioMS Medical Announces 2008 Year End Results 4BioMS Medical Announces 2008 Year End Results 5BioMS Medical Announces 2008 Year End Results 6BioMS Medical Announces 2008 Year End Results 7BioMS Medical Announces 2008 Year End Results 8BioMS Medical Announces 2008 Year End Results 9BioMS Medical Announces 2008 Year End Results 10BioMS Medical Announces 2008 Year End Results 11Gentag, Inc. Engages US and UK Firms to Explore Strategic Options 2
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ...
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research and Markets ... of the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is a technology ... measures the overall facial feature of a person such ...
(Date:12/11/2014)...  That blood pressure plays a role in human health has ... term for high blood pressure – was first described as ... that,s used in measuring blood pressure was invented in 1896. ... hypertension, its triggers and its effects. In fact, recent findings ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... Nov. 12, 2013 One of the most comprehensive ... today, demonstrating an unprecedented level of genetic variation that ... ovarian cancer. The study highlights potential new pathways for ... multiple disease sites may be required for effective targeted ...
... as clear as glass, or why bakers use sugar, even ... in the American Chemical Society,s (ACS,) latest Bytesize Science ... . "Everything that happens in the kitchen is science," ... of it, you,re going to have more power over your ...
... protein, they tend to eat a small amount at ... at dinner. New research presented today at The ... eating high protein sausage and egg-based breakfasts curbed hunger ... and syrup) or skipping breakfast, in 18-55-year-old women., ...
Cached Biology News:Clinical ovarian cancers display extensive genetic heterogeneity, study suggests multiple treatment 2Clinical ovarian cancers display extensive genetic heterogeneity, study suggests multiple treatment 3
... Product Mouse monoclonal [SPM278] to ... Small cell lung carcinoma N592 live cells ... with Human. Not yet tested in other ... of the major glycoproteins of basement membrane, ...
TLN2 Antibody...
Chicken polyclonal to Thaumatin 2 ( Abpromise for all tested applications). Antigen: Full length Thaumatin 2...
XIAP Antibody...
Biology Products: